Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Baxter Healthcare Corporation
FDA Inspection
•Baxter Healthcare Corporation•December 21, 2018

Baxter Healthcare Corporation – FDA Inspection, Dec 21, 2018

Record Details

This FDA Inspection record concerns Baxter Healthcare Corporation, with an inspection on December 21, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Baxter Healthcare Corporation
Inspection Date
December 21, 2018
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Jose E. Melendez (FDA Associated Person)
  • Laurimer Kuilan-Torres (Issuing Officer)
  • Miguel A. Martinez
View Company Profile

ID · 98db3fae-15e1-4bbf-8a62-75a50c9b73ab

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1075479
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

12
  1. 21 CFR 211.58Buildings not maintained in good state of repair
  2. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  3. 21 CFR 211.194(d)Laboratory equipment calibration records
  4. 21 CFR 211.67(c)Cleaning/maintenance records not kept
  5. 21 CFR 211.170(b)Reserve samples identified, representative, stored
  6. 21 CFR 211.165(e)Test methods
  7. 21 CFR 211.100(a)Absence of Written Procedures
  8. 21 CFR 211.192Investigations of discrepancies, failures
  9. 21 CFR 211.22(d)Procedures not in writing, fully followed
  10. 21 CFR 211.166(a)(1)Sample size - test intervals

Showing 10 of 12 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Baxter Healthcare Corporation

13
DateClassificationOfficeProject area
September 29, 2026Not classifiedSan Juan District OfficeDrug Quality Assurance
July 19, 2024VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 30, 2021NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
October 3, 2016OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 1, 2015OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 13 other inspections on the company page
Other documents for Baxter Healthcare Corporation
  • FDA Inspection 1338220 - 2026-09-29
  • FDA Inspection 1240745 - 2024-07-19
  • FDA Inspection 1149615 - 2021-07-30
  • FDA Inspection 985599 - 2016-10-03
  • FDA Inspection 925338 - 2015-05-01

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Baxter Healthcare Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.